Reps. Davis, Tenney push for genetically targeted heart disease technologies

May 15, 2026 - 03:31

A bipartisan effort in the House is aiming to accelerate the development and availability of genetically targeted technologies for heart disease. Representatives Don Davis, a Democrat from North Carolina, and Claudia Tenney, a Republican from New York, announced on Thursday that they are backing legislation to expand access to these advanced treatments, often referred to as GTT. The lawmakers argue that current regulatory and reimbursement frameworks lag behind the rapid progress in genetic medicine, leaving many patients without options for conditions rooted in specific genetic mutations.

The proposed bill seeks to streamline approval pathways and encourage research into therapies that can address the underlying causes of cardiovascular disease rather than just managing symptoms. Supporters say this approach could be a game-changer for patients with inherited heart conditions, such as certain forms of cardiomyopathy or familial hypercholesterolemia, where standard treatments often fall short. The legislation also aims to ensure that Medicare and private insurers cover these therapies once they are proven effective.

Both Davis and Tenney emphasized that heart disease remains the leading cause of death in the United States, and that precision medicine offers a new frontier. They called on their colleagues to move the bill forward, citing strong support from patient advocacy groups and medical researchers. The push comes as the House prepares for a broader debate on healthcare innovation and genetic technology regulation.